Amarin Corp Plcuk (AMRN) Revenue Growth (5y) (2018 - 2026)
Amarin Corp Plcuk (AMRN) Revenue Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn |
| 10 | Amarin Corp Plcuk | 5.84 Bn | 5.66 Bn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.51% |
| Dec 31, 2025 | -21.70% |
| Sep 30, 2025 | -20.51% |
| Jun 30, 2025 | -11.67% |
| Mar 31, 2025 | -22.98% |
| Dec 31, 2024 | -15.34% |
| Sep 30, 2024 | -17.76% |
| Jun 30, 2024 | -7.71% |
| Mar 31, 2024 | -5.06% |
| Dec 31, 2023 | -0.69% |
| Sep 30, 2023 | 3.61% |
| Jun 30, 2023 | 8.78% |
| Mar 31, 2023 | 14.38% |
| Dec 31, 2022 | 10.87% |
| Sep 30, 2022 | 13.67% |
| Jun 30, 2022 | 15.86% |
| Mar 31, 2022 | 22.26% |
| Dec 31, 2021 | 29.60% |
| Sep 30, 2021 | 34.36% |
| Jun 30, 2021 | 36.08% |